AlphaCrest Capital Management’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-48,518
Closed -$1.77M 872
2022
Q3
$1.77M Buy
48,518
+23,384
+93% +$1.01M 0.11% 276
2022
Q2
$1.2M Buy
25,134
+6,737
+37% +$312K 0.06% 582
2022
Q1
$973K Buy
18,397
+2,772
+18% +$146K 0.05% 554
2021
Q4
$802K Buy
+15,625
New +$922K 0.03% 903
2021
Q2
Sell
-2,625
Closed -$320K 1325
2021
Q1
$320K Buy
+2,625
New +$437K 0.02% 997
2020
Q3
Sell
-2,237
Closed -$252K 1173
2020
Q2
$252K Buy
+2,237
New +$230K 0.04% 718

Other funds holding PRLB

AlphaCrest Capital Management's PRLB Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Protolabs (PRLB) in Q4 2022, closing a stake of 48,518 shares — an estimated $1.77M sold.

AlphaCrest Capital Management first reported a position in PRLB in Q2 2020 and held it in 6 quarters. The position peaked at $1.77M in Q3 2022. 199 funds tracked by Wall St. Rank hold PRLB as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Protolabs position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 48,518 Protolabs shares in Q4 2022, an estimated $1.77M.
  • AlphaCrest Capital Management first reported a position in Protolabs in Q2 2020 and held it in 6 quarters.
  • AlphaCrest Capital Management's Protolabs position peaked at $1.77M in Q3 2022.
  • 199 funds tracked by Wall St. Rank held Protolabs as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.